Cargando…
Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression
BACKGROUND: The relationship between proton-pump inhibitor (PPI) use and chronic kidney disease (CKD) progression remains controversial. Specifically, there is a lack of data evaluating renal outcomes in established CKD patients. The aim of our study is to determine the risk of progression to end-st...
Autores principales: | Cholin, Liza, Ashour, Tarek, Mehdi, Ali, Taliercio, Jonathan J., Daou, Remy, Arrigain, Susana, Schold, Jesse D., Thomas, George, Nally, Joseph, Nakhoul, Nazih L., Nakhoul, Georges N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281649/ https://www.ncbi.nlm.nih.gov/pubmed/34266395 http://dx.doi.org/10.1186/s12882-021-02449-0 |
Ejemplares similares
-
Dysnatremias, Mortality, and Kidney Failure in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
por: Hassanein, Mohamed, et al.
Publicado: (2022) -
Correction to: Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020) -
Urine Sediment Examination: Comparison Between Laboratory-Performed Versus Nephrologist-Performed Microscopy and Accuracy in Predicting Pathologic Diagnosis in Patients with Acute Kidney Injury
por: Fadel, Remy, et al.
Publicado: (2023) -
Serum magnesium, mortality and disease progression in chronic kidney disease
por: Azem, Rami, et al.
Publicado: (2020) -
“What do you think about nephrology?” A national survey of internal medicine residents
por: Nakhoul, Georges N., et al.
Publicado: (2021)